Mona Dahdah

VP of R&D, Operations, Quality Assurance & Regulatory at Sonex Health

Mona Dahdah is an accomplished professional with extensive experience in research and development, operations, and quality management within the medical device industry. Currently serving as Vice President of R&D, Operations and Quality at Sonex Health since May 2022, Mona previously held the role of R&D Director at Boston Scientific from August 2018 to May 2022. Additional experience includes positions as Vice President of R&D and Operations and Director of Program Management at NxThera, and Program Manager at both Dahdah Consulting, Inc and Project Leadership Services. Early career roles included Engineering Supervisor and Senior R&D Engineer at American Medical Systems and Process Development Engineer at Boston Scientific. Mona Dahdah earned a Bachelor of Science in Mechanical Engineering and a Bachelor of Arts in Philosophy from the University of St. Thomas.

Location

St. Paul, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Sonex Health

Sonex Health reduces invasiveness, improves safety, and lowers the cost of care through transformative ultrasound.“Refined simplicity” is the guiding principle behind Sonex Health. To drive efforts and innovations that result in elegant, effective solutions to some of the healthcare system’s most pressing needs. Mayo Clinic physicians DarrylBarnes, MD and Jay Smith, MD, and business operations expert Aaron Keenan founded Sonex Health in 2014. Sonex Health has developed the SX-One MicroKnife(R) with Meerkat Technology™ to treat carpal tunnel syndrome in a novel fashion, termed Micro-invasive Carpal Tunnel Release. This innovation allows a procedure that once took place in an operating room to be safely and effectively performed in a surgery center or office setting, resulting in rapid patient recovery, improved cosmesis, and reduced costs.The ultra-low-profile SX-One MicroKnife with Meerkat Technology is an innovative surgical device that enables physicians to perform Micro-invasive Carpal Tunnel Release surgery through a single micro-incision under ultrasound guidance, or with a traditional mini-open incision without ultrasound guidance. The SX-One MicroKnife utilizes a micro-incision that’s up to five times smaller than the incision made during traditional CTR surgery—an incision so small, it can be closed with a small adhesive bandage or strip instead of sutures or stitches. The result is a low-trauma surgical environment that has been associated with a more rapid recovery. Immobilization is unnecessary so patients can begin rehabilitation and get back to their jobs and lives.


Employees

11-50

Links